Support our non-partisan non-profit newsroom 💜 Donate now

The finances behind preventing HIV and AIDS

The prices for HIV-prevention medication PrEP can range from 50 cents a day to north of $18,000 annually.
Emtricitabine and tenofovir disoproxil fumarate is a daily pill that can prevent HIV infections.
Dylan Miettinen/Marketplace

In time for National HIV Testing Day, progress made on prevention

Jun 28, 2019
A new recommendation makes PrEP, a drug that helps prevent the spread of HIV, free for many more Americans
Jeffery Beall / Wikimedia

The cost of preventing the spread of HIV? Upwards of $1,600 a month

Feb 5, 2019
President Trump is expected to call for an end to HIV transmission by 2030. The drug known as PrEP may be key.
AIDS Healthcare Foundation (AHF) and AIDS patients march to protest budget cuts to AIDS services proposed by California Governor Arnold Schwarzenegger on June 5, 2009 in Hollywood, California. 
David McNew/Getty Images

How the deaths of gay men became a commodity

Oct 15, 2018
A haunting money story from the AIDS epidemic that all started in the pages of gay men's lifestyle magazines.
Magazines require a high grade of coated paper, one that ink will lay well on.
Bennett Purser/Marketplace

How the deaths of gay men became a commodity

Oct 15, 2018
A haunting money story from the AIDS epidemic that all started in the pages of gay men's lifestyle magazines.
Magazines require a high grade of coated paper, one that ink will lay well on.
Bennett Purser/Marketplace

The first HIV/AIDS drug was fast-tracked 30 years ago. Some lament that process.

Mar 20, 2017
It was 30 years ago this week that the Food and Drug Administration approved the first  treatment for HIV/AIDS, the drug AZT. At a time when the number of AIDS-related deaths was skyrocketing, AZT was rushed into the approval process. But some of the early advocates of the drug’s fast-tracking ended up lamenting that process. […]

New trial for HIV/AIDS vaccine

Nov 30, 2016
The first large-scale trial in seven years.
A clinic official in Bangkok, Thailand displays a small bottle containing the AIDSVAX B/E vaccine back in 2002.  A new HIV/AIDS trial will be administered in South Africa today.
Paula Bronstein/Getty Images

For public good, not for profit.

Complaint alleges discrimination against HIV/AIDS patients

Sep 6, 2016
Large insurers discourage high-cost patients, lawsuit says.
A lawsuit filed by the Center for Health Law & Policy Innovation alleges that some insurers are refusing to cover high-priced medications for HIV/AIDS patients.
STAN HONDA/AFP/Getty Images

Striving to get to 'HIV zero'

Jan 22, 2015
Washington, D.C., and other cities are making inroads against spread of HIV/AIDS.